IL144958A0 - Camptothecin derivatives having antitumor activity - Google Patents
Camptothecin derivatives having antitumor activityInfo
- Publication number
- IL144958A0 IL144958A0 IL14495800A IL14495800A IL144958A0 IL 144958 A0 IL144958 A0 IL 144958A0 IL 14495800 A IL14495800 A IL 14495800A IL 14495800 A IL14495800 A IL 14495800A IL 144958 A0 IL144958 A0 IL 144958A0
- Authority
- IL
- Israel
- Prior art keywords
- antitumor activity
- camptothecin derivatives
- camptothecin
- derivatives
- antitumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99830124A EP1044977B1 (en) | 1999-03-09 | 1999-03-09 | Camptothecin derivatives having antitumor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
IL144958A0 true IL144958A0 (en) | 2002-06-30 |
Family
ID=8243303
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14495800A IL144958A0 (en) | 1999-03-09 | 2000-03-08 | Camptothecin derivatives having antitumor activity |
IL144958A IL144958A (en) | 1999-03-09 | 2001-08-16 | Derivatives of camphutothcin, processes for their preparation, distillate preparations containing them and their use in the preparation of drugs for the treatment of tumors |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL144958A IL144958A (en) | 1999-03-09 | 2001-08-16 | Derivatives of camphutothcin, processes for their preparation, distillate preparations containing them and their use in the preparation of drugs for the treatment of tumors |
Country Status (39)
Country | Link |
---|---|
US (2) | US6242457B1 (zh) |
EP (1) | EP1044977B1 (zh) |
JP (1) | JP4610743B2 (zh) |
KR (1) | KR100702085B1 (zh) |
CN (1) | CN1139592C (zh) |
AR (1) | AR022860A1 (zh) |
AT (1) | ATE216998T1 (zh) |
AU (1) | AU774174B2 (zh) |
BG (1) | BG65032B1 (zh) |
BR (1) | BR0008840B1 (zh) |
CA (1) | CA2362760C (zh) |
CO (1) | CO5180590A1 (zh) |
CZ (1) | CZ304465B6 (zh) |
DE (1) | DE69901379T2 (zh) |
DK (1) | DK1044977T3 (zh) |
EA (1) | EA003605B1 (zh) |
EE (1) | EE04679B1 (zh) |
EG (1) | EG23999A (zh) |
ES (1) | ES2175919T3 (zh) |
HK (1) | HK1031222A1 (zh) |
HR (1) | HRP20010667B1 (zh) |
HU (1) | HU229506B1 (zh) |
IL (2) | IL144958A0 (zh) |
IS (1) | IS2003B (zh) |
ME (2) | ME00017B (zh) |
MX (1) | MXPA01009081A (zh) |
NO (1) | NO328363B1 (zh) |
NZ (1) | NZ513393A (zh) |
PE (1) | PE20001485A1 (zh) |
PL (1) | PL222208B1 (zh) |
PT (1) | PT1044977E (zh) |
RS (1) | RS50405B (zh) |
SI (1) | SI1044977T1 (zh) |
SK (1) | SK287561B6 (zh) |
TN (1) | TNSN00045A1 (zh) |
TR (1) | TR200102603T2 (zh) |
TW (1) | TWI272272B (zh) |
WO (1) | WO2000053607A1 (zh) |
ZA (1) | ZA200107408B (zh) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4790911B2 (ja) | 1999-01-13 | 2011-10-12 | アルケミア オンコロジー ピーティワイ リミテッド | 薬物の効力を増強するための組成物および方法 |
US7105492B2 (en) * | 1999-03-09 | 2006-09-12 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Camptothecin derivatives having antitumor activity |
FR2794123B1 (fr) * | 1999-05-28 | 2001-07-27 | Aventis Pharma Sa | Preparation de derives de la camptothecine et de la nothapodytine |
US6352996B1 (en) * | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US9066919B2 (en) * | 2000-07-14 | 2015-06-30 | Alchemia Oncology Pty Limited | Hyaluronan as a chemo-sensitizer in the treatment of cancer |
AUPQ879500A0 (en) * | 2000-07-14 | 2000-08-10 | Meditech Research Limited | Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease |
US20040029906A1 (en) * | 2001-07-31 | 2004-02-12 | Michael Christman | Inhibitors of dna polymerase sigma |
US20050042303A1 (en) * | 2001-08-27 | 2005-02-24 | Brown Tracey Jean | Therapeutic protocols |
WO2003033525A1 (en) * | 2001-10-12 | 2003-04-24 | Debio Recherche Pharmacuetique S.A. | Amino-substituted camptothecin polymer derivatives and use of the same for the manufacture of a medicament |
ITRM20020306A1 (it) * | 2002-05-31 | 2003-12-01 | Sigma Tau Ind Farmaceuti | Esteri in posizione 20 di camptotecine. |
ITRM20020305A1 (it) * | 2002-05-31 | 2003-12-01 | Sigma Tau Ind Farmaceuti | Camptotecine con anello lattonico modificato. |
FR2852606A1 (fr) * | 2003-03-18 | 2004-09-24 | Inst Nat Sante Rech Med | Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie |
US20040204435A1 (en) * | 2003-04-09 | 2004-10-14 | Joachim Liehr | Alternating treatment with topoisomerase I and topoisomerase II inhibitors |
ITRM20030344A1 (it) * | 2003-07-14 | 2005-01-15 | Ist Naz Stud Cura Dei Tumori | 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi. |
RU2006137657A (ru) * | 2004-03-26 | 2008-05-10 | Новартис АГ (CH) | Применение производных камптотецина для лечения пролиферативных заболеваний с использованием схемы лечения с фиксированной дозой |
JP5170741B2 (ja) | 2004-04-27 | 2013-03-27 | ウェルスタット バイオロジクス コーポレイション | ウイルスおよびカンプトテシン類を使用する癌の処置 |
ITRM20040240A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 7 con antagonisti delle integrine. |
ITRM20040242A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine. |
ITRM20040241A1 (it) * | 2004-05-13 | 2004-08-13 | Ist Naz Stud Cura Dei Tumori | Camptotecine coniugate in posizione 20 con antagonisti delle integrine. |
ITRM20040288A1 (it) * | 2004-06-11 | 2004-09-11 | Sigma Tau Ind Farmaceuti | Uso della 7-t-butossiimminometilcamptotecina per la preparazione di un medicamento per il trattamento delle neoplasie dell'utero. |
CN100334089C (zh) * | 2004-07-21 | 2007-08-29 | 王洋 | 一种9-硝基喜树碱的生产方法 |
GT200500310A (es) * | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
PL1827437T3 (pl) | 2004-12-15 | 2013-06-28 | Sigma Tau Ind Farmaceuti | Połączenia środków terapeutycznych do leczenia raka |
CA2590756C (en) * | 2004-12-21 | 2014-09-02 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Stereoselective process and crystalline forms of a camptothecin |
SA06270147B1 (ar) | 2005-06-09 | 2009-12-22 | نوفارتيس ايه جي | عملية لتخليق 5-(مثيل–1h–إيميدازول–1-يل )–3-(ثلاثي فلـورو مثيل)–بنزامـين |
AU2006270297B2 (en) | 2005-07-14 | 2013-01-17 | Wellstat Biologics Corporation | Cancer treatment using viruses, fluoropyrimidines and camptothecins |
AU2006274509B2 (en) * | 2005-07-27 | 2012-01-19 | Alchemia Oncology Pty Limited | Therapeutic protocols using hyaluronan |
ITRM20050418A1 (it) * | 2005-08-04 | 2007-02-05 | Sigma Tau Ind Farmaceuti | Sistemi terapeutici a rilascio immediato per il migliorato assorbimento orale di 7-[(e)-t-butilossimminometil] camptotecina. |
CA2617873A1 (en) * | 2005-08-10 | 2007-02-15 | Novartis Ag | Formulations for 7-(t-butoxy)iminomethyl camptothecin |
EA013877B1 (ru) * | 2005-09-07 | 2010-08-30 | Алкемиа Онколоджи Пти Лимитед | Терапевтические композиции, содержащие гиалуроновую кислоту и терапевтические антитела, а также способы лечения |
PL1962850T3 (pl) * | 2005-12-21 | 2012-07-31 | Sigma Tau Ind Farmaceuti | Leczenie lekoopornych nowotworów |
EP1989212B1 (en) | 2006-02-17 | 2013-06-19 | Cascade Prodrug Inc. | Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs |
EP1998809B1 (en) | 2006-03-30 | 2014-06-25 | Drais Pharmaceuticals, Inc. | Camptothecin-cell penetrating peptide conjugates and pharmaceutical compositions containing the same |
AU2008210511A1 (en) * | 2007-02-01 | 2008-08-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Pharmaceutical composition comprising a campothecin derivative |
EP2120948A1 (en) * | 2007-02-13 | 2009-11-25 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Broad-spectrum anti-cancer treatment based on iminocamptothecin derivatives |
CN101784277A (zh) * | 2007-08-01 | 2010-07-21 | 希格马托制药工业公司 | 儿科肿瘤的治疗 |
EP2096113A1 (en) * | 2008-02-05 | 2009-09-02 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | 9-substituted camptothecin derivatives as antitumor compounds |
TWI482621B (zh) | 2009-12-23 | 2015-05-01 | Sigma Tau Ind Farmaceuti | 青蒿素基藥物與其他化學治療劑的抗癌組合物 |
KR20180058759A (ko) | 2015-09-25 | 2018-06-01 | 제트와이 테라퓨틱스 인코포레이티드 | 폴리사카라이드-비타민 접합체를 포함하는 미립자를 기재로 하는 약물 제제 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
DE69233169T2 (de) * | 1991-11-15 | 2004-05-27 | Smithkline Beecham Corp. | Cisplatin und Topotecan enthaltende Zusammensetzung als antitumor. |
US5614529A (en) * | 1994-09-22 | 1997-03-25 | Research Triangle Institute | Inhibition of plasmodia parasites by camptothecin compounds |
US5972955A (en) * | 1995-06-06 | 1999-10-26 | Dr. Reddy's Research Foundation | Water soluble C-ring analogues of 20(S)-camptothecin |
GB9512670D0 (en) * | 1995-06-21 | 1995-08-23 | Sod Conseils Rech Applic | Camptothecin analogues |
IT1282673B1 (it) * | 1996-02-23 | 1998-03-31 | Ist Naz Stud Cura Dei Tumori | Derivati della camptotecina e loro uso come agenti antitumorali |
BR9711319B1 (pt) * | 1996-08-19 | 2009-08-11 | derivados de camptotecina altamente lipofìlicos. |
-
1999
- 1999-03-09 AT AT99830124T patent/ATE216998T1/de active
- 1999-03-09 DK DK99830124T patent/DK1044977T3/da active
- 1999-03-09 EP EP99830124A patent/EP1044977B1/en not_active Expired - Lifetime
- 1999-03-09 ES ES99830124T patent/ES2175919T3/es not_active Expired - Lifetime
- 1999-03-09 DE DE69901379T patent/DE69901379T2/de not_active Expired - Lifetime
- 1999-03-09 SI SI9930010T patent/SI1044977T1/xx unknown
- 1999-03-09 PT PT99830124T patent/PT1044977E/pt unknown
-
2000
- 2000-02-22 US US09/507,928 patent/US6242457B1/en not_active Expired - Lifetime
- 2000-03-07 TW TW089104090A patent/TWI272272B/zh not_active IP Right Cessation
- 2000-03-07 EG EG20000293A patent/EG23999A/xx active
- 2000-03-08 JP JP2000604043A patent/JP4610743B2/ja not_active Expired - Fee Related
- 2000-03-08 RS YUP-643/01A patent/RS50405B/sr unknown
- 2000-03-08 CA CA002362760A patent/CA2362760C/en not_active Expired - Fee Related
- 2000-03-08 PE PE2000000206A patent/PE20001485A1/es not_active Application Discontinuation
- 2000-03-08 CN CNB008047804A patent/CN1139592C/zh not_active Expired - Fee Related
- 2000-03-08 ME MEP-2008-40A patent/ME00017B/me unknown
- 2000-03-08 TR TR2001/02603T patent/TR200102603T2/xx unknown
- 2000-03-08 CO CO00016957A patent/CO5180590A1/es active IP Right Grant
- 2000-03-08 NZ NZ513393A patent/NZ513393A/xx not_active IP Right Cessation
- 2000-03-08 IL IL14495800A patent/IL144958A0/xx unknown
- 2000-03-08 EE EEP200100466A patent/EE04679B1/xx not_active IP Right Cessation
- 2000-03-08 KR KR1020017011336A patent/KR100702085B1/ko not_active IP Right Cessation
- 2000-03-08 MX MXPA01009081A patent/MXPA01009081A/es unknown
- 2000-03-08 ME MEP-40/08A patent/MEP4008A/xx unknown
- 2000-03-08 AR ARP000101013A patent/AR022860A1/es not_active Application Discontinuation
- 2000-03-08 HU HU0200210A patent/HU229506B1/hu not_active IP Right Cessation
- 2000-03-08 AU AU31604/00A patent/AU774174B2/en not_active Ceased
- 2000-03-08 TN TNTNSN00045A patent/TNSN00045A1/fr unknown
- 2000-03-08 WO PCT/EP2000/001570 patent/WO2000053607A1/en active IP Right Grant
- 2000-03-08 PL PL355094A patent/PL222208B1/pl unknown
- 2000-03-08 BR BRPI0008840-4A patent/BR0008840B1/pt not_active IP Right Cessation
- 2000-03-08 SK SK1164-2001A patent/SK287561B6/sk not_active IP Right Cessation
- 2000-03-08 CZ CZ2001-3077A patent/CZ304465B6/cs not_active IP Right Cessation
- 2000-03-08 EA EA200100954A patent/EA003605B1/ru not_active IP Right Cessation
- 2000-11-29 HK HK00107660A patent/HK1031222A1/xx not_active IP Right Cessation
- 2000-12-22 US US09/741,818 patent/US6589939B2/en not_active Expired - Lifetime
-
2001
- 2001-07-31 IS IS6031A patent/IS2003B/is unknown
- 2001-08-10 BG BG105810A patent/BG65032B1/bg unknown
- 2001-08-16 IL IL144958A patent/IL144958A/en not_active IP Right Cessation
- 2001-08-24 NO NO20014128A patent/NO328363B1/no not_active IP Right Cessation
- 2001-09-07 ZA ZA200107408A patent/ZA200107408B/xx unknown
- 2001-09-10 HR HR960321A patent/HRP20010667B1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG23999A (en) | Camptothecin derivatives having antitumor activity | |
EG23817A (en) | 4-Phenyl-pyridine derivatives | |
IL147924A0 (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents | |
IL146100A0 (en) | 4,5,6,7-tetrahydroindazole derivatives as antitumor agents | |
GC0000183A (en) | 3-Phenyl-pyridine derivatives | |
GC0000338A (en) | 5-Phenyl-pyrimidine derivatives | |
HK1044940A1 (zh) | 異噁唑咪唑羧酰胺衍生物 | |
GC0000191A (en) | 4-Phenyl-pyrimidine derivatives | |
HU0003938D0 (en) | Quinolin-4-yl derivatives | |
IL138777A0 (en) | Quinolin-4-yl derivatives i | |
GB0026485D0 (en) | ›-Carboline derivatives | |
HK1048638A1 (zh) | Cyclopenteneone衍生物 | |
HK1045987A1 (zh) | 3-氨基-2-苄基-1-苯基-丙烷衍生物 | |
GC0000256A (en) | Ethanesulfonyl-piperidine derivatives | |
HK1045698A1 (zh) | 阿維菌素衍生物 | |
AP2001002327A0 (en) | 1-Trifluoromethyl-4-hydroxy-7- piperidinylaminomethy lchroman derivatives | |
GB0131034D0 (en) | Benzocyclodecane derivatives with antitumor activity | |
GC0000200A (en) | Camptothecin derivatives having antitumor activity | |
AU5769500A (en) | Ucf116 derivatives as antitumor agents | |
GB9907134D0 (en) | Antimor napthylcombretastatin derivatives | |
HK1043987A1 (zh) | 硫-羥吲衍生物 |